UBS Group’s Direxion Daily Healthcare Bull 3X ETF CURE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-6,500
Closed -$162K 8901
2014
Q4
$162K Buy
+6,500
New +$153K ﹤0.01% 5244

Other funds holding CURE

UBS Group's CURE Position: Q2 2026 in Review

UBS Group opened a new position in Direxion Daily Healthcare Bull 3X ETF (CURE) in Q2 2026: 999 shares worth $112K. The stake represents ﹤0.01% of the portfolio and ranks #7123 among its holdings. This is a return to the name: UBS Group previously reported a position in CURE as recently as Q4 2025.

UBS Group first reported a position in CURE in Q1 2015 and has held it in 32 quarters since. The position peaked at $549K in Q1 2025. 19 funds tracked by Wall St. Rank hold CURE as of Q2 2026.

  • UBS Group held 999 shares of Direxion Daily Healthcare Bull 3X ETF worth $112K as of Q2 2026.
  • Direxion Daily Healthcare Bull 3X ETF was a new UBS Group position in Q2 2026.
  • Direxion Daily Healthcare Bull 3X ETF made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #7123 holding.
  • UBS Group first reported a position in Direxion Daily Healthcare Bull 3X ETF in Q1 2015 and has held it in 32 quarters since.
  • UBS Group's Direxion Daily Healthcare Bull 3X ETF position peaked at $549K in Q1 2025.
  • 19 funds tracked by Wall St. Rank held Direxion Daily Healthcare Bull 3X ETF as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.